October 17, 2014
Almost everyone agrees that depression is a disease that endangers millions of lives and livelihoods. It also costs businesses billions of dollars each year. But what should business do about its treatment? That's where the arguments begin. One approach favors "talk therapy" and medication with antidepressants, while the other relies on treatment that's more pharmaceutical than psychiatric. Plus: Declining coverage for behavioral health.